Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| hematopoietic stem cell | 7 studies | 37% ± 11% | |
| mesothelial cell | 4 studies | 38% ± 8% | |
| hematopoietic precursor cell | 3 studies | 41% ± 18% | |
| smooth muscle cell | 3 studies | 22% ± 5% | |
| endothelial cell | 3 studies | 27% ± 7% | |
| chondrocyte | 3 studies | 39% ± 4% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 56% ± 27% | |
| erythroblast | 3 studies | 23% ± 2% |
Insufficient scRNA-seq data for expression of CYTL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 99% | 458.90 | 242 / 245 | 80% | 6.31 | 403 / 502 |
| breast | 95% | 288.58 | 438 / 459 | 62% | 3.77 | 697 / 1118 |
| thymus | 95% | 255.31 | 621 / 653 | 57% | 3.90 | 343 / 605 |
| brain | 54% | 76.73 | 1415 / 2642 | 97% | 32.21 | 684 / 705 |
| skin | 68% | 98.49 | 1223 / 1809 | 79% | 59.08 | 374 / 472 |
| esophagus | 91% | 154.10 | 1316 / 1445 | 55% | 3.33 | 100 / 183 |
| uterus | 100% | 497.61 | 170 / 170 | 43% | 14.49 | 197 / 459 |
| bladder | 95% | 482.05 | 20 / 21 | 40% | 4.96 | 203 / 504 |
| intestine | 89% | 169.26 | 858 / 966 | 36% | 1.72 | 188 / 527 |
| lung | 68% | 186.51 | 395 / 578 | 55% | 3.97 | 636 / 1155 |
| stomach | 81% | 150.90 | 291 / 359 | 37% | 2.05 | 106 / 286 |
| ovary | 49% | 57.21 | 88 / 180 | 68% | 10.05 | 291 / 430 |
| adrenal gland | 47% | 36.68 | 122 / 258 | 53% | 2.98 | 123 / 230 |
| blood vessel | 98% | 2790.21 | 1311 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 91% | 209.75 | 1098 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 86% | 14.78 | 69 / 80 |
| kidney | 22% | 16.55 | 20 / 89 | 57% | 4.84 | 511 / 901 |
| pancreas | 16% | 11.17 | 53 / 328 | 60% | 3.24 | 106 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 62% | 2.63 | 18 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 40% | 1.48 | 18 / 45 |
| spleen | 32% | 37.12 | 77 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 22% | 18.63 | 205 / 929 | 0% | 0 | 0 / 0 |
| heart | 17% | 18.87 | 146 / 861 | 0% | 0 | 0 / 0 |
| liver | 0% | 0.19 | 1 / 226 | 9% | 0.40 | 37 / 406 |
| muscle | 3% | 2.65 | 22 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0006366 | Biological process | transcription by RNA polymerase II |
| GO_0002062 | Biological process | chondrocyte differentiation |
| GO_0050650 | Biological process | chondroitin sulfate proteoglycan biosynthetic process |
| GO_0048839 | Biological process | inner ear development |
| GO_1990079 | Biological process | cartilage homeostasis |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005102 | Molecular function | signaling receptor binding |
| Gene name | CYTL1 |
| Protein name | Cytokine like 1 Cytokine-like protein 1 (Protein C17) |
| Synonyms | C4orf4 UNQ1942/PRO4425 |
| Description | |
| Accessions | Q9NRR1 H0Y9X7 ENST00000506508.1 ENST00000509419.1 H0Y8Q4 ENST00000307746.9 |
